IBDEI1NT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27767,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,27767,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,27767,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,27768,0)
 ;;=D05.92^^132^1320^33
 ;;^UTILITY(U,$J,358.3,27768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27768,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,27768,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,27768,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,27769,0)
 ;;=D05.91^^132^1320^35
 ;;^UTILITY(U,$J,358.3,27769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27769,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,27769,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,27769,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,27770,0)
 ;;=D05.90^^132^1320^31
 ;;^UTILITY(U,$J,358.3,27770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27770,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,27770,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,27770,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,27771,0)
 ;;=D51.0^^132^1320^185
 ;;^UTILITY(U,$J,358.3,27771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27771,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,27771,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,27771,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,27772,0)
 ;;=D51.1^^132^1320^186
 ;;^UTILITY(U,$J,358.3,27772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27772,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,27772,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,27772,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,27773,0)
 ;;=D51.9^^132^1320^188
 ;;^UTILITY(U,$J,358.3,27773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27773,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,27773,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,27773,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,27774,0)
 ;;=D68.0^^132^1320^190
 ;;^UTILITY(U,$J,358.3,27774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27774,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,27774,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,27774,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,27775,0)
 ;;=C88.0^^132^1320^191
 ;;^UTILITY(U,$J,358.3,27775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27775,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,27775,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,27775,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,27776,0)
 ;;=C91.02^^132^1320^3
 ;;^UTILITY(U,$J,358.3,27776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27776,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,27776,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,27776,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,27777,0)
 ;;=C92.02^^132^1320^6
 ;;^UTILITY(U,$J,358.3,27777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27777,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,27777,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,27777,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,27778,0)
 ;;=D09.3^^132^1320^43
 ;;^UTILITY(U,$J,358.3,27778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27778,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,27778,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,27778,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,27779,0)
 ;;=C22.0^^132^1320^84
 ;;^UTILITY(U,$J,358.3,27779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27779,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,27779,1,4,0)
 ;;=4^C22.0
